NATIONS FINANCIAL GROUP INC, /IA/ /ADV
Position in PGEN — Precigen, Inc.
CIK 1109767
CEDAR RAPIDS, IA
Position in PGEN
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$59,985
New position
Shares Held
15,500
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $3,466,943 across 9 Biotechnology names. PGEN ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,490 | $2,004,964 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
15,177 | $980,889 | |
| 3 | NVCT |
Nuvectis Pharma, Inc.
|
13,000 | $100,490 | |
| 4 | VNDA |
Vanda Pharmaceuticals Inc.
|
14,000 | $96,740 | |
| 5 | IMRX |
Immuneering Corp
|
17,000 | $89,590 | |
| 6 | PGEN |
Precigen, Inc.
This page
|
15,500 | $59,985 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
22,500 | $58,050 | |
| 8 | HYPD |
Hyperion Defi, Inc.
|
11,125 | $38,381 |
All Filings in PGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,985 | 15,500 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||